In ovarian cancer, ascitic HE4 and CA125 have been proposed as useful adjuncts when cytology is inconclusive, with multiple studies reporting sensitivities above 80–90% [6,22,32,36,45]. Here, WFDC2 is linked to ovarian carcinoma.